Your session is about to expire
← Back to Search
Clinolipid for Essential Fatty Acid Deficiency
Study Summary
This trial will compare two types of fat emulsions given to hospitalized pediatric patients to see which one is more likely to prevent a deficiency of essential fatty acids, and to see how safe and effective either option is.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 4 trial • 101 Patients • NCT04555044Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How widespread is this research endeavor?
"At this time, the 9 enrolling sites that are part of this trial can be found in Orlando, Provo and New Haven, as well as 6 other cities. To reduce travelling expenses if you decide to participate, select the clinic closest to your home."
How many participants is this research program accommodating?
"Unfortunately, this medical trial has ended recruitment. It was initially posted on January 22 2021 and its last update occurred on October 10 2022. If you wish to take part in a clinical study, there are two ascorbic acid deficiency research studies and seventeen Clinolipid trials actively seeking patients."
Are there any other studies which have previously explored the effects of Clinolipid?
"Initial exploration of clinolipid began in 2014 at the University of Rochester Medical Center, and since then 77 trials have been concluded. Currently 17 more live studies are being conducted, with a bulk of these happening around Orlando, Florida."
Is enrollment still taking place for this trial?
"The information on clinicaltrials.gov suggests that enrollment for this particular trial has ceased. Initially listed on the 22nd of January 2021 and most recently modified on 10th October 2022, it appears that there are no more openings available in this study; however, 19 other trials have open spots presently."
What purpose does Clinolipid serve in medical treatment?
"Clinolipid is a pharmaceutical remedy for treating parenteral nutrition, supplementing nutrients and counteracting ascorbic acid deprivation."
Has the FDA given its approval to Clinolipid?
"There is a high level of confidence in Clinolipid's safety, as the drug has already been approved and is now undergoing Phase 4 trials. As such, it received a score of 3."
Share this study with friends
Copy Link
Messenger